Pulse oximetry for the diagnosis and management of acute respiratory distress syndrome

KD Wick, MA Matthay, LB Ware - The Lancet Respiratory Medicine, 2022 - thelancet.com
The diagnosis of acute respiratory distress syndrome (ARDS) traditionally requires
calculation of the ratio of partial pressure of arterial oxygen to fraction of inspired oxygen …

[HTML][HTML] Noninvasive respiratory support and patient self-inflicted lung injury in COVID-19: a narrative review

D Battaglini, C Robba, L Ball, PL Silva, FF Cruz… - British Journal of …, 2021 - Elsevier
COVID-19 pneumonia is associated with hypoxaemic respiratory failure, ranging from mild
to severe. Because of the worldwide shortage of ICU beds, a relatively high number of …

Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic …

DL Grieco, LS Menga, M Cesarano, T Rosà, S Spadaro… - Jama, 2021 - jamanetwork.com
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …

High-dose dexamethasone and oxygen support strategies in intensive care unit patients with severe COVID-19 acute hypoxemic respiratory failure: the COVIDICUS …

L Bouadma, A Mekontso-Dessap, C Burdet… - JAMA internal …, 2022 - jamanetwork.com
Importance The benefit of high-dose dexamethasone and oxygenation strategies vs
standard of care for patients with severe acute hypoxemic respiratory failure (AHRF) caused …

High-flow nasal oxygen for severe hypoxemia: oxygenation response and outcome in patients with COVID-19

VM Ranieri, T Tonetti, P Navalesi, S Nava… - American Journal of …, 2022 - atsjournals.org
Rationale: The “Berlin definition” of acute respiratory distress syndrome (ARDS) does not
allow inclusion of patients receiving high-flow nasal oxygen (HFNO). However, several …

Clinical trends among US adults hospitalized with COVID-19, March to December 2020: a cross-sectional study

S Garg, K Patel, H Pham, M Whitaker… - Annals of internal …, 2021 - acpjournals.org
Background: The COVID-19 pandemic has caused substantial morbidity and mortality.
Objective: To describe monthly clinical trends among adults hospitalized with COVID-19 …

Attributable mortality of ventilator-associated pneumonia among patients with COVID-19

CH Vacheron, A Lepape, A Savey… - American journal of …, 2022 - atsjournals.org
Rationale: Patients with a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection are at higher risk of ventilator-associated pneumonia (VAP) and may have an …

[HTML][HTML] ROX index as predictor of high flow nasal cannula therapy success in acute respiratory failure due to SARS-CoV-2

S Ferrer, J Sancho, I Bocigas, E Bures, H Mora… - Respiratory …, 2021 - Elsevier
Abstract Background High-Flow Nasal Cannula (HFNC) therapy is useful treatment in
patients with acute respiratory failure (ARF). The ROX index (ratio of pulse oximetry/fraction …

[HTML][HTML] Safety and outcome of high-flow nasal oxygen therapy outside ICU setting in hypoxemic patients with COVID-19

ML Janssen, Y Türk, SJ Baart, W Hanselaar… - Critical Care …, 2024 - journals.lww.com
OBJECTIVE: High-flow nasal oxygen (HFNO) therapy is frequently applied outside ICU
setting in hypoxemic patients with COVID-19. However, safety concerns limit more …

Management of COVID-19-associated acute respiratory failure with alternatives to invasive mechanical ventilation: high-flow oxygen, continuous positive airway …

B Bonnesen, JUS Jensen, KN Jeschke… - Diagnostics, 2021 - mdpi.com
Patients admitted to hospital with coronavirus disease 2019 (COVID-19) may develop acute
respiratory failure (ARF) with compromised gas exchange. These patients require oxygen …